» Articles » PMID: 15855322

Differential Association of Basal and Postprandial Plasma Ghrelin with Leptin, Insulin, and Type 2 Diabetes

Overview
Journal Diabetes
Specialty Endocrinology
Date 2005 Apr 28
PMID 15855322
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

To gain further insight into the regulatory role of insulin and leptin on plasma ghrelin, 56 normal weight, 128 normoinsulinemic obese, 121 hyperinsulinemic obese, and 30 type 2 diabetic normoinsulinemic and 75 type 2 diabetic hyperinsulinemic obese patients were examined. In the obese subjects, basal hyperinsulinemia was associated with significantly lower ghrelin independent of BMI, age, and leptin. In normoinsulinemic (normal weight and normoinsulinemic obese) subjects, ghrelin was inversely related to stepwise increasing leptin. Multiple regression analysis and matching for insulin revealed a significant negative interaction of ghrelin with leptin but not insulin. In type 2 diabetic normoinsulinemic subjects, ghrelin was significantly lower compared with that in normoinsulinemic obese subjects. In type 2 diabetic hyperinsulinemic subjects, ghrelin was significantly lower than in normoinsulinemic subjects, whereas no further reduction was observed compared with hyperinsulinemic obese subjects. The postprandial decrease was significantly attenuated in normoinsulinemic obese and hyperinsulinemic obese subjects (-214.8 +/- 247 pg/ml [normal weight], -137.6 +/- 107 pg/ml [normoinsulinemic obese], -85.5 +/- 69 pg/ml [hyperinsulinemic obese], P < 0.001; mean +/- SD), whereas type 2 diabetes had no independent postprandial effect. In conclusion, the present data support the concept that leptin could be of importance for suppression of basal ghrelin during moderate weight gain in normoinsulinemic subjects, whereas hyperinsulinemia but not leptin is responsible in more severe obesity. Postprandial suppression of ghrelin is attenuated by as yet unknown mechanisms that are related to body weight but not to insulin or type 2 diabetes.

Citing Articles

Appetite-related Gut Hormone Responses to Feeding Across the Life Course.

Holliday A, Horner K, Johnson K, Dagbasi A, Crabtree D J Endocr Soc. 2025; 9(2):bvae223.

PMID: 39777204 PMC: 11702868. DOI: 10.1210/jendso/bvae223.


Intraduodenal nutrient infusion differentially alters intestinal nutrient sensing, appetite, and satiety responses in lean and obese subjects.

Sundaresan S, Johnson C, Dixon K, Dole M, Kilkelly D, Antoun J Am J Clin Nutr. 2023; 118(3):646-656.

PMID: 37661107 PMC: 10517208. DOI: 10.1016/j.ajcnut.2023.06.011.


Differences in gastrointestinal hormones and appetite ratings between individuals with and without obesity-A systematic review and meta-analysis.

Aukan M, Coutinho S, Pedersen S, Rae Simpson M, Martins C Obes Rev. 2022; 24(2):e13531.

PMID: 36416279 PMC: 10078575. DOI: 10.1111/obr.13531.


The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases.

Russo C, Valle M, Russo A, Malaguarnera L Int J Mol Sci. 2022; 23(21).

PMID: 36362220 PMC: 9654207. DOI: 10.3390/ijms232113432.


Mucosal and hormonal adaptations after Roux-en-Y gastric bypass.

Feris F, McRae A, Kellogg T, McKenzie T, Ghanem O, Acosta A Surg Obes Relat Dis. 2022; 19(1):37-49.

PMID: 36243547 PMC: 9797451. DOI: 10.1016/j.soard.2022.08.020.